![]() We continue to assess the situation and adapt accordingly. ![]() With that in mind, this week AAA announced a range of additional measures to protect and support our associates around the world.Īnnounced this week, AAA has extended its guidance for all AAA associates within Europe, US and Canada to work from home until May 1, 2020, with the exception of those working in laboratories, manufacturing sites and in the field. AAA and Novartis continue to provide additional resources like coaching and learning tools – irrespective of place of work.Īs the coronavirus (COVID-19) situation continues to evolve, our primary concern at Advanced Accelerators Applications (AAA), a Novartis Company, remains the health and safety of our associates and patients globally. To help associates, the local leadership team will provide local guidance and support. No one should feel forced or pressured to return. So the decision to return is for each associate to make in accordance with their manager. This means each country leadership team, in accordance with local authorities, will decide when and how to loosen or tighten restrictions and voluntarily offer associates the opportunity to return.ĪAA fully recognizes that some associates are eager to return to the office while others may prefer to continue to work from home. The health, wellbeing and safety of our associates remains paramount. This is applicable to all countries and markets. BioRx works hand-in-hand with our end user software, BioDose.Starting May 11, 2020, Accelerators Applications (AAA), a Novartis Company, will introduce company-wide a flexible working model that invites associates, country-by-country, to return to the office and restart on-site field activities, when possible and appropriate, based on the respective local situation and risk assessment. Capable of streamlining inventory receipt, processing orders, shipping and invoicing, BioRx provides a comprehensive software solution to efficiently operate our nuclear pharmacy. ![]() Radiopharmacy of Indianapolis utilizes the BioRx pharmacy software system, the nuclear pharmacy industry’s most technologically advanced management system. ![]() World’s First Real-Time Nuclear Pharmacy Management System ROI offers CE support through SNMMI offering local events, vendor CE training through Curium and Lantheus Medical Imaging, and technologist events sponsored by ROI. Understanding that educational is key to our technologists we strive to provide a robust variety of education programs that focus on the needs of the Nuclear Medicine Technologist. ROI partners with both Curium and Lantheus Medical Imaging to provide the highest quality nuclear products with the security of limited service interruptions. We are happy to announce that as of JanuROI will be 100% LEU. We were the first in the market to provide LEU and have provided to some customers for over three years. ROI has been a key driver in supporting the transition to non-HEU Tc-99m products. We have been proud to offer Vizient value to qualifying customers. Vizient, formerly Novation is a strong player in the nuclear medicine industry and a valued ROI partner since 2012. We are currently working with Advanced Accelerator Applications (AAA) to offer Ga-68 NETSPOT® which is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. ROI is focused on collaboration to support growth in nuclear medicine industry. Our staff focuses on delivering your products in a timely fashion and meeting the needs of your patient schedules. We source our radiopharmaceuticals from multiple vendors, minimizing supply interruption during shortage situations. ROI offers a variety of diagnostic and therapeutic products throughout the day with efficient delivery options.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |